Pinuccia Valagussa


Ontology type: schema:Person     


Person Info

NAME

Pinuccia

SURNAME

Valagussa

Publications in SciGraph latest 50 shown

  • 2017-12 Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer in BREAST CANCER RESEARCH
  • 2014-04 Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis in BONE MARROW TRANSPLANTATION
  • 2012-04 Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II) in BREAST CANCER RESEARCH AND TREATMENT
  • 2009 History of Adjuvant Therapy in ADJUVANT THERAPY FOR BREAST CANCER
  • 2007-04 Comment to “Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor” by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776–782 in ANNALS OF SURGICAL ONCOLOGY
  • 2006-09 Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation in LEUKEMIA
  • 2006-06 Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005 in BREAST CANCER RESEARCH AND TREATMENT
  • 2005-09 Comment to Jatoi et al. report in BREAST CANCER RESEARCH AND TREATMENT
  • 2005-05 Adjuvant chemotherapy for operable breast cancer: old vs new schema in BREAST CANCER RESEARCH
  • 2004-12 Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour in BREAST CANCER RESEARCH
  • 2004-08 Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients in BREAST CANCER RESEARCH
  • 2002-09 Double-Peaked Time Distribution of Mortality for Breast Cancer Patients Undergoing Mastectomy in BREAST CANCER RESEARCH AND TREATMENT
  • 2001-12 Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2001-08 Does surgery modify growth kinetics of breast cancer micrometastases? in BRITISH JOURNAL OF CANCER
  • 2000-02 Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience in MEDICAL ONCOLOGY
  • 1999-02 Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of ‘cures’ in BREAST CANCER RESEARCH AND TREATMENT
  • 1998-03 Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications in BRITISH JOURNAL OF CANCER
  • 1998 Summary in ADJUVANT THERAPY OF PRIMARY BREAST CANCER VI
  • 1998 Putting Taxanes to Work in Operable Breast Cancer: A Search for Selective Indications from Empirical Studies in ADJUVANT THERAPY OF PRIMARY BREAST CANCER VI
  • 1997-09 Computer simulation of a breast cancer metastasis model in BREAST CANCER RESEARCH AND TREATMENT
  • 1996-06 Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy in BREAST CANCER RESEARCH AND TREATMENT
  • 1996 Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer in ADJUVANT THERAPY OF BREAST CANCER V
  • 1993 Long-Term Sequelae from Adjuvant Chemotherapy in ADJUVANT THERAPY OF BREAST CANCER IV
  • 1993 Primary Chemotherapy for Resectable Breast Cancer in ADJUVANT THERAPY OF BREAST CANCER IV
  • 1991 Alternating versus hybrid MOPP-ABVD in Hodgkin’s disease: The Milan experience in ANNALS OF ONCOLOGY
  • 1991 Adjuvant Chemotherapy Programs in Node-Negative Breast Cancer in HIGH-RISK BREAST CANCER
  • 1990-05 Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy in BREAST CANCER RESEARCH AND TREATMENT
  • 1989 The Milan Experience with Adjuvant Chemotherapy in Premenopausal Breast Cancer in ADJUVANT THERAPY OF PRIMARY BREAST CANCER
  • 1989 Adjuvant Chemotherapy for Node-Negative Breast Cancer Patients in ADJUVANT THERAPY OF PRIMARY BREAST CANCER
  • 1989 Salvage Treatments in Relapsing Resectable Breast Cancer in ADJUVANT THERAPY OF PRIMARY BREAST CANCER
  • 1989 Hodgkin’s Disease: The Milan Cancer Institute Experience with MOPP and ABVD in NEW ASPECTS IN THE DIAGNOSIS AND TREATMENT OF HODGKIN’S DISEASE
  • 1989 Adjuvant Systemic Therapy in SURGICAL ONCOLOGY
  • 1989 Chemotherapy of Advanced Disease in BREAST CANCER
  • 1987-11 Four-drug sequential regimen in advanced breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1986-10 Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1986-02 Reply in BREAST CANCER RESEARCH AND TREATMENT
  • 1986 Adjuvant Chemotherapy of Breast Cancer: The Milan Cancer Institute Trials in GYNECOLOGY AND OBSTETRICS
  • 1985-10 Adjuvant chemotherapy in postmenopausal women: Results of sequential noncross-resistant regimens in WORLD JOURNAL OF SURGERY
  • 1985-10 Adjuvant CMF chemotherapy in operable breast cancer: Ten years later in WORLD JOURNAL OF SURGERY
  • 1985-06 Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1985 Current status of the Milan trials for Hodgkin’s disease in adults in MALIGNANT LYMPHOMAS AND HODGKIN’S DISEASE: EXPERIMENTAL AND THERAPEUTIC ADVANCES
  • 1984 Relationship Between Estrogen Receptors and CMF Adjuvant Chemotherapy in CLINICAL INTEREST OF STEROID HORMONE RECEPTORS IN BREAST CANCER
  • 1984 CMF Adjuvant Programs at the Milan Cancer Institute in ADJUVANT CHEMOTHERAPY OF BREAST CANCER
  • 1984 New Adjuvant Trials for Resectable Breast Cancer at the Istituto Nazionale Tumori of Milan in CLINICAL INTEREST OF STEROID HORMONE RECEPTORS IN BREAST CANCER
  • 1984 Contribution of Prognostic Factors to Adjuvant Chemotherapy in Breast Cancer in ADJUVANT CHEMOTHERAPY OF BREAST CANCER
  • 1984 Adjuvant Programs for Postmenopausal Women with Node-Positive Breast Cancer:Preliminary Analysis of 5-Year Results in ADJUVANT CHEMOTHERAPY OF BREAST CANCER
  • 1983-04 T3b-T4 breast cancer: factors affecting results in combined modality treatments in CLINICAL & EXPERIMENTAL METASTASIS
  • 1982-12 12 versus 6 cycles of adjuvant CMF in breast cancer — Reply in BREAST CANCER RESEARCH AND TREATMENT
  • 1982-03 Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion in BREAST CANCER RESEARCH AND TREATMENT
  • 1982 Multimodal Therapy with CMF in Resectable Breast Cancer with Positive Axillary Nodes: The Milan Institute Experience in ADJUVANT THERAPIES OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.476276.6", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.18887.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416188.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.465337.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.469474.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266623.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417108.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.434440.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411308.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411083.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7839.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5606.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419849.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7605.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417149.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411450.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5390.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410345.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7010.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6292.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4708.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4305.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418596.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417068.c", 
            "type": "Organization"
          }
        ], 
        "familyName": "Valagussa", 
        "givenName": "Pinuccia", 
        "id": "sg:person.0715002305.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715002305.49"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:05", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_774.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0715002305.49'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0715002305.49'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0715002305.49'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0715002305.49'


     

    This table displays all metadata directly associated to this object as RDF triples.

    72 TRIPLES      10 PREDICATES      39 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0715002305.49 schema:affiliation N43aeccebe57d472c8fb597f6b7d008c4
    2 https://www.grid.ac/institutes/grid.18887.3e
    3 https://www.grid.ac/institutes/grid.21925.3d
    4 https://www.grid.ac/institutes/grid.240145.6
    5 https://www.grid.ac/institutes/grid.266623.5
    6 https://www.grid.ac/institutes/grid.38142.3c
    7 https://www.grid.ac/institutes/grid.410345.7
    8 https://www.grid.ac/institutes/grid.411083.f
    9 https://www.grid.ac/institutes/grid.411308.f
    10 https://www.grid.ac/institutes/grid.411450.5
    11 https://www.grid.ac/institutes/grid.412468.d
    12 https://www.grid.ac/institutes/grid.416188.2
    13 https://www.grid.ac/institutes/grid.417068.c
    14 https://www.grid.ac/institutes/grid.417108.b
    15 https://www.grid.ac/institutes/grid.417149.e
    16 https://www.grid.ac/institutes/grid.417893.0
    17 https://www.grid.ac/institutes/grid.418596.7
    18 https://www.grid.ac/institutes/grid.419849.9
    19 https://www.grid.ac/institutes/grid.4305.2
    20 https://www.grid.ac/institutes/grid.434440.3
    21 https://www.grid.ac/institutes/grid.465337.0
    22 https://www.grid.ac/institutes/grid.469474.c
    23 https://www.grid.ac/institutes/grid.4708.b
    24 https://www.grid.ac/institutes/grid.5390.f
    25 https://www.grid.ac/institutes/grid.5606.5
    26 https://www.grid.ac/institutes/grid.6292.f
    27 https://www.grid.ac/institutes/grid.7010.6
    28 https://www.grid.ac/institutes/grid.7605.4
    29 https://www.grid.ac/institutes/grid.7839.5
    30 schema:familyName Valagussa
    31 schema:givenName Pinuccia
    32 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715002305.49
    33 schema:sdDatePublished 2019-03-07T15:05
    34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    35 schema:sdPublisher N568a8adc08174f5fbe8dd37d877992c1
    36 sgo:license sg:explorer/license/
    37 sgo:sdDataset persons
    38 rdf:type schema:Person
    39 N43aeccebe57d472c8fb597f6b7d008c4 schema:affiliation https://www.grid.ac/institutes/grid.476276.6
    40 sgo:isCurrent true
    41 rdf:type schema:OrganizationRole
    42 N568a8adc08174f5fbe8dd37d877992c1 schema:name Springer Nature - SN SciGraph project
    43 rdf:type schema:Organization
    44 https://www.grid.ac/institutes/grid.18887.3e schema:Organization
    45 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    46 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    47 https://www.grid.ac/institutes/grid.266623.5 schema:Organization
    48 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    49 https://www.grid.ac/institutes/grid.410345.7 schema:Organization
    50 https://www.grid.ac/institutes/grid.411083.f schema:Organization
    51 https://www.grid.ac/institutes/grid.411308.f schema:Organization
    52 https://www.grid.ac/institutes/grid.411450.5 schema:Organization
    53 https://www.grid.ac/institutes/grid.412468.d schema:Organization
    54 https://www.grid.ac/institutes/grid.416188.2 schema:Organization
    55 https://www.grid.ac/institutes/grid.417068.c schema:Organization
    56 https://www.grid.ac/institutes/grid.417108.b schema:Organization
    57 https://www.grid.ac/institutes/grid.417149.e schema:Organization
    58 https://www.grid.ac/institutes/grid.417893.0 schema:Organization
    59 https://www.grid.ac/institutes/grid.418596.7 schema:Organization
    60 https://www.grid.ac/institutes/grid.419849.9 schema:Organization
    61 https://www.grid.ac/institutes/grid.4305.2 schema:Organization
    62 https://www.grid.ac/institutes/grid.434440.3 schema:Organization
    63 https://www.grid.ac/institutes/grid.465337.0 schema:Organization
    64 https://www.grid.ac/institutes/grid.469474.c schema:Organization
    65 https://www.grid.ac/institutes/grid.4708.b schema:Organization
    66 https://www.grid.ac/institutes/grid.476276.6 schema:Organization
    67 https://www.grid.ac/institutes/grid.5390.f schema:Organization
    68 https://www.grid.ac/institutes/grid.5606.5 schema:Organization
    69 https://www.grid.ac/institutes/grid.6292.f schema:Organization
    70 https://www.grid.ac/institutes/grid.7010.6 schema:Organization
    71 https://www.grid.ac/institutes/grid.7605.4 schema:Organization
    72 https://www.grid.ac/institutes/grid.7839.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...